Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species

Detalles Bibliográficos
Main Authors:	Dicks, M, Spencer, A, Edwards, N, Gilbert, S, Hill, S, Cottingham, MG
Formato:	Journal article
Publicado:	2011

Títulos similares

Uncovering the mechanisms of adenovirus vector immunogenicity
por: Dicks, M, et al.
Publicado: (2013)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
por: Dicks, M, et al.
Publicado: (2012)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
por: Matthew D J Dicks, et al.
Publicado: (2012-01-01)

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
por: Eriko Padron-Regalado, et al.
Publicado: (2022-08-01)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
por: Warimwe, G, et al.
Publicado: (2013)

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
por: Dicks, M, et al.
Publicado: (2015)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer (nee Russell), K, et al.
Publicado: (2017)

Novel adenovirus vaccine vectors
por: Dicks, M
Publicado: (2013)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
por: Dicks, M, et al.
Publicado: (2015)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Katie Ewer, et al.
Publicado: (2017-12-01)

Simian adenoviruses as vaccine vectors
por: Morris, S, et al.
Publicado: (2016)

Simian adenoviruses as vaccine vectors
por: Morris, S, et al.
Publicado: (2016)

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
por: Alcock, R, et al.
Publicado: (2010)

Adenoviral vectors as novel vaccines for influenza.
por: Coughlan, L, et al.
Publicado: (2015)

Immunogenicity and cross-reactivity of rhesus adenoviral vectors
por: Iampietro, M, et al.
Publicado: (2018)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
por: Lynda Coughlan
Publicado: (2020-05-01)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Marta Ulaszewska, et al.
Publicado: (2023-01-01)

MAIT cell activation augments adenovirus vector vaccine immunogenicity
por: Provine, N, et al.
Publicado: (2021)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
por: Goodman, A, et al.
Publicado: (2009)

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
por: Jingao Guo, et al.
Publicado: (2018-07-01)

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
por: Reyes-Sandoval, A, et al.
Publicado: (2008)

Adenovirus vector and mRNA vaccines: mechanisms regulating their immunogenicity
por: Provine, NM, et al.
Publicado: (2022)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors
por: Cottingham, MG, et al.
Publicado: (2011)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
por: Cottingham, MG, et al.
Publicado: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
por: Reyes-Sandoval, A, et al.
Publicado: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity
por: Reyes-Sandoval, A, et al.
Publicado: (2012)

Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
por: Reyes-Sandoval, A, et al.
Publicado: (2011)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
por: Biswas, S, et al.
Publicado: (2011)

Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.
por: Draper, S, et al.
Publicado: (2013)

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
por: Folegatti, P, et al.
Publicado: (2021)

Using multivalent adenoviral vectors for HIV vaccination.
por: Linlin Gu, et al.
Publicado: (2013-01-01)

An Adenoviral Vector Based Vaccine for Rhodococcus equi.
por: Carla Giles, et al.
Publicado: (2016-01-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
por: Folegatti, P, et al.
Publicado: (2019)

Immunogenicity of a pre-erythrocytic-stage malaria insert ME-trap encoded by novel simian adenoviral vectors
por: Reyes-Sandoval, A, et al.
Publicado: (2005)

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
por: Pedro M. Folegatti, et al.
Publicado: (2021-03-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
por: Pedro M. Folegatti, et al.
Publicado: (2019-05-01)

Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.
por: Bruna de Andrade Pereira, et al.
Publicado: (2015-01-01)

Pandemic-response adenoviral vector and RNA vaccine manufacturing
por: Zoltán Kis, et al.
Publicado: (2022-03-01)

The use of adenoviral vectors in gene therapy and vaccine approaches
por: Natália Meneses Araújo, et al.
Publicado: (2022-10-01)

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
por: Ekramy E. Sayedahmed, et al.
Publicado: (2020-10-01)